Concepedia

Publication | Open Access

Effect of rosuvastatin on diabetic polyneuropathy: a randomized, double-blind, placebo-controlled Phase IIa study

43

Citations

21

References

2014

Year

Abstract

The severity, symptoms, and nerve conduction parameters of DPN improved after 12 weeks of treatment with rosuvastatin. These beneficial effects appear to be attributable to reductions in lipid peroxidation and oxidative stress.

References

YearCitations

2001

8.9K

2006

536

2001

458

2003

403

2011

270

1993

200

2013

144

2003

110

2005

105

2011

104

Page 1